Free Cash Flow (FCF): $1.75B
The free cash flow (FCF) is $1.75B. It is above its 12-month average by 3.25% ($1.69B).
RMD Free Cash Flow (FCF)
Reported quarterly free cash flow; no daily interpolation.
RMD Quarterly Free Cash Flow Growth (YoY)
Free Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
RMD Average Free Cash Flow (FCF) Chart
RMD Current vs Average Free Cash Flow (FCF) Chart
RMD Free Cash Flow (FCF) Metrics
FREE CASH FLOW (FCF)
$1.75B
FREE CASH FLOW (FCF) AVG TTM
$1.69B
FREE CASH FLOW (FCF) AVG 3Y
$1.24B
FREE CASH FLOW (FCF) AVG 5Y
$952.68M
FREE CASH FLOW (FCF) AVG 10Y
$548.13M
FREE CASH FLOW (FCF) AVG 15Y
$401.08M
FREE CASH FLOW (FCF) AVG 20Y
$308.52M
CURRENT VS TTM AVG
+3.25%
CURRENT VS 3Y AVG
+40.65%
CURRENT VS 5Y AVG
+83.50%
CURRENT VS 10Y AVG
+218.94%
CURRENT VS 15Y AVG
+335.87%
CURRENT VS 20Y AVG
+466.64%
FCF Analysis
Free Cash Flow (TTM)
$1.75B
FCF Yield
5.99%
Price/FCF
16.7
Formula: FCF = Operating Cash Flow - Capital Expenditures
Why FCF matters:
- Shows actual cash available (not accounting earnings)
- Funds dividends, buybacks, and debt reduction
- Less susceptible to accounting manipulation than net income
- Key metric for DCF valuation models
Free Cash Flow (FCF) Formula & Definition
Free Cash Flow represents the cash a company generates after accounting for capital expenditures. It's the cash available for dividends, buybacks, debt reduction, or reinvestment.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Free Cash Flow (FCF) FAQ
- What is the free cash flow (FCF) for ResMed Inc. (RMD)?
- The free cash flow (FCF) for RMD stock is $1.75B.
- What is the TTM average free cash flow (FCF) for ResMed Inc. (RMD)?
- The TTM average free cash flow (FCF) for RMD stock is $1.69B.
- What is the 3Y average free cash flow (FCF) for ResMed Inc. (RMD)?
- The 3Y average free cash flow (FCF) for RMD stock is $1.24B.
- What is the 5Y average free cash flow (FCF) for ResMed Inc. (RMD)?
- The 5Y average free cash flow (FCF) for RMD stock is $952.68M.
- What is the 10Y average free cash flow (FCF) for ResMed Inc. (RMD)?
- The 10Y average free cash flow (FCF) for RMD stock is $548.13M.
- What is the 15Y average free cash flow (FCF) for ResMed Inc. (RMD)?
- The 15Y average free cash flow (FCF) for RMD stock is $401.08M.
- What is the 20Y average free cash flow (FCF) for ResMed Inc. (RMD)?
- The 20Y average free cash flow (FCF) for RMD stock is $308.52M.
RMD Free Cash Flow (FCF) History
| DATE | FREE CASH FLOW (FCF) |
|---|---|
| 2026-03-31 | $1.75B |
| 2025-09-30 | $1.77B |
| 2025-03-31 | $1.56B |
| 2024-09-30 | $1.35B |
| 2024-03-31 | $1.07B |
| 2023-09-30 | $792.43M |
| 2023-03-31 | $407.69M |
| 2022-09-30 | $304.85M |
| 2022-03-31 | $343.67M |
| 2021-09-30 | $397.18M |
| 2021-03-31 | $733.32M |
| 2020-09-30 | $683.96M |
| 2020-03-31 | $504.78M |
| 2019-09-30 | $486.82M |
| 2019-03-31 | $373.83M |
| 2018-09-30 | $390.37M |
| 2018-03-31 | $443.58M |
| 2017-09-30 | $349.08M |
| 2017-03-31 | $362.37M |
| 2016-09-30 | $446.07M |
| 2016-03-31 | $425.77M |
| 2015-09-30 | $350.99M |
| 2015-03-31 | $320.43M |
| 2014-09-30 | $301.61M |
| 2014-03-31 | $321.35M |
| 2013-09-30 | $339.65M |
| 2013-03-31 | $308.92M |
| 2012-09-30 | $317.48M |
| 2012-03-31 | $292.10M |
| 2011-09-30 | $233.81M |
| 2011-03-31 | $196.04M |
| 2010-09-30 | $120.18M |
| 2010-03-31 | $125.10M |
| 2009-09-30 | $139.95M |
| 2009-03-31 | $128.66M |
| 2008-09-30 | $85.74M |
| 2008-03-31 | $30.57M |
| 2007-09-30 | $25.32M |
| 2007-03-31 | $12.87M |
| 2006-09-30 | $17.90M |
| 2006-03-31 | $-7.67M |
| 2005-09-30 | $-1.41M |
| 2005-03-31 | $35.73M |
| 2004-09-30 | $26.92M |
| 2004-03-31 | $20.25M |
| 2003-09-30 | $31.94M |
| 2003-03-31 | $16.70M |
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell